Fair Value (Details) (USD $) | 3 Months Ended | 12 Months Ended | 3 Months Ended | | | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | 3 Months Ended | | 3 Months Ended | 12 Months Ended | 3 Months Ended | 12 Months Ended | | | | | | |
Mar. 31, 2014 | Mar. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Mar. 31, 2014 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 | Mar. 31, 2014 | Dec. 31, 2013 |
Private Equity Technology, Media and Telecommunications [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Fund [Member] | Consolidated Private Equity Investment Venture Capital Fund [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] |
| Median [Member] | Median [Member] | | | | | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Technology, Media and Telecommunications [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Private Equity Healthcare and Cleantech [Member] | Level 1 [Member] | Level 1 [Member] | Level 2 [Member] | Level 2 [Member] | Level 3 [Member] | Level 3 [Member] |
| | | | | | | | | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | | | Minimum [Member] | Minimum [Member] | Maximum [Member] | Maximum [Member] | | | | | | |
Assets, Fair Value Disclosure [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Money markets | ' | ' | ' | ' | ' | ' | ' | $124,619,000 | $153,630,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | $124,619,000 | $153,630,000 | $0 | $0 | $0 | $0 |
U.S. Treasury bills | ' | ' | ' | ' | ' | ' | ' | 884,756,000 | 964,953,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 0 | 0 | 884,756,000 | 964,953,000 | 0 | 0 |
Available-for-sale [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Equity securities | ' | ' | ' | ' | ' | ' | ' | 5,279,000 | 4,794,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 5,279,000 | 4,794,000 | 0 | 0 | 0 | 0 |
Fixed income securities | ' | ' | ' | ' | ' | ' | ' | 262,000 | 64,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 262,000 | 64,000 | 0 | 0 | 0 | 0 |
Trading [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Equity securities | ' | ' | ' | ' | ' | ' | ' | 331,210,000 | 314,166,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 329,799,000 | 312,931,000 | 1,411,000 | 1,235,000 | 0 | 0 |
Fixed income securities | ' | ' | ' | ' | ' | ' | ' | 198,051,000 | 198,338,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 195,304,000 | 194,085,000 | 2,747,000 | 4,253,000 | 0 | 0 |
Long exchange-traded options | ' | ' | ' | ' | ' | ' | ' | 18,826,000 | 22,621,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 18,826,000 | 22,621,000 | 0 | 0 | 0 | 0 |
Derivatives | ' | ' | ' | ' | ' | ' | ' | 3,652,000 | 3,285,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 144,000 | 290,000 | 3,508,000 | 2,995,000 | 0 | 0 |
Private equity | ' | ' | ' | ' | ' | ' | ' | 67,678,000 | 80,851,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 11,264,000 | 19,836,000 | 5,670,000 | 8,934,000 | 50,744,000 | 52,081,000 |
Total assets measured at fair value | ' | ' | ' | ' | ' | ' | ' | 1,634,333,000 | 1,742,702,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 685,497,000 | 708,251,000 | 898,092,000 | 982,370,000 | 50,744,000 | 52,081,000 |
Securities sold not yet purchased [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Short equities - corporate | ' | ' | ' | ' | ' | ' | ' | 119,359,000 | 46,978,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 119,359,000 | 46,978,000 | 0 | 0 | 0 | 0 |
Short exchange-traded options | ' | ' | ' | ' | ' | ' | ' | 10,902,000 | 25,005,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 10,902,000 | 25,005,000 | 0 | 0 | 0 | 0 |
Derivatives | ' | ' | ' | ' | ' | ' | ' | 7,014,000 | 6,311,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 2,348,000 | 2,542,000 | 4,666,000 | 3,769,000 | 0 | 0 |
Total liabilities measured at fair value | ' | ' | ' | ' | ' | ' | ' | 137,275,000 | 78,294,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | 132,609,000 | 74,525,000 | 4,666,000 | 3,769,000 | 0 | 0 |
Fair value measurement Level 3 reconciliation [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Balance as of beginning of period | 52,081,000 | 76,953,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Transfers (out) in, net | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Purchases | 501,000 | 10,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Sales | -1,121,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Realized gains (losses), net | 1,121,000 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Unrealized gains (losses), net | -1,838,000 | -2,110,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Balance as of end of period | 50,744,000 | 74,853,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Percentage of consolidated venture capital fund the Company owned (in hundredths) | 10.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Percentage of consolidated venture capital fund non-controlling interests owned (in hundredths) | 90.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Quantitative information about Level 3 fair value measurements [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Fair value | ' | ' | ' | ' | ' | ' | ' | ' | ' | 15,457,000 | 13,956,000 | ' | ' | ' | ' | 2,539,000 | 2,892,000 | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Valuation technique | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'Market comparable companies | ' | ' | ' | ' | ' | 'Market comparable companies | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Revenue multiple | ' | ' | ' | 7.2 | 12.5 | ' | ' | ' | ' | ' | ' | 2 | 2.5 | 2.5 | 3.5 | ' | ' | 0.9 | [1] | 1.2 | [2] | 16.8 | [1] | 49 | [2] | ' | ' | ' | ' | ' | ' |
Discount rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | 18.00% | 18.00% | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Discount years | ' | ' | ' | ' | ' | ' | ' | ' | ' | '1 year 9 months | '1 year | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
R & D Multiple | ' | ' | ' | 5.3 | 11 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0.3 | [1] | 1.1 | [2] | 10 | [1] | 17.1 | [2] | ' | ' | ' | ' | ' | ' |
Discount for lack of marketability and risk factors (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | | 50.00% | | ' | | 60.00% | | ' | ' | ' | ' | ' | ' |
Description of investment | ' | ' | 'communications, consumer, digital media, healthcare and information technology markets | ' | ' | 'energy sector | 'clean energy, resource and energy efficiency and other sustainable industries | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Private equity investment at fair value | ' | ' | 27,200,000 | ' | ' | 5,400,000 | 100,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Unfunded commitments to investments | ' | ' | 10,100,000 | ' | ' | 2,200,000 | 200,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
Transfers out of Level 2 | $3,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | | ' | | ' | | ' | | ' | ' | ' | ' | ' | ' |
|
[1] | The median for the Healthcare and Cleantech revenue multiple is 7.2; the median R&D multiple is 5.3. |
[2] | The median for the Healthcare and Cleantech revenue multiple is 12.5; the median R&D multiple is 11.0. |